Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma.

Dogrusöz M, Ruschel Trasel A, Cao J, Ҫolak S, van Pelt SI, Kroes WGM, Teunisse AFAS, Alsafadi S, van Duinen SG, Luyten GPM, van der Velden PA, Amaro A, Pfeffer U, Jochemsen AG, Jager MJ.

Cancers (Basel). 2019 Aug 2;11(8). pii: E1104. doi: 10.3390/cancers11081104.

2.

Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology.

Vivet-Noguer R, Tarin M, Roman-Roman S, Alsafadi S.

Cancers (Basel). 2019 Jul 20;11(7). pii: E1019. doi: 10.3390/cancers11071019. Review.

3.

A variant erythroferrone disrupts iron homeostasis in SF3B1-mutated myelodysplastic syndrome.

Bondu S, Alary AS, Lefèvre C, Houy A, Jung G, Lefebvre T, Rombaut D, Boussaid I, Bousta A, Guillonneau F, Perrier P, Alsafadi S, Wassef M, Margueron R, Rousseau A, Droin N, Cagnard N, Kaltenbach S, Winter S, Kubasch AS, Bouscary D, Santini V, Toma A, Hunault M, Stamatoullas A, Gyan E, Cluzeau T, Platzbecker U, Adès L, Puy H, Stern MH, Karim Z, Mayeux P, Nemeth E, Park S, Ganz T, Kautz L, Kosmider O, Fontenay M.

Sci Transl Med. 2019 Jul 10;11(500). pii: eaav5467. doi: 10.1126/scitranslmed.aav5467.

PMID:
31292266
4.

Evolutionary Routes in Metastatic Uveal Melanomas Depend on MBD4 Alterations.

Rodrigues M, Mobuchon L, Houy A, Alsafadi S, Baulande S, Mariani O, Marande B, Ait Rais K, Van der Kooij MK, Kapiteijn E, Gassama S, Gardrat S, Barnhill RL, Servois V, Dendale R, Putterman M, Tick S, Piperno-Neumann S, Cassoux N, Pierron G, Waterfall JJ, Roman-Roman S, Mariani P, Stern MH.

Clin Cancer Res. 2019 Sep 15;25(18):5513-5524. doi: 10.1158/1078-0432.CCR-19-1215. Epub 2019 Jun 21.

PMID:
31227496
5.

Risk factors of primary and secondary restless legs syndrome among a middle-aged population in Saudi Arabia: A community-based study.

Alsafadi S, Abaalkhail B, Wali SO, Aljammali K, Alotaiby B, Zakaria I, Sabbahi H.

Ann Thorac Med. 2018 Jul-Sep;13(3):175-181. doi: 10.4103/atm.ATM_344_17.

6.

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib.

Quek L, David MD, Kennedy A, Metzner M, Amatangelo M, Shih A, Stoilova B, Quivoron C, Heiblig M, Willekens C, Saada V, Alsafadi S, Vijayabaskar MS, Peniket A, Bernard OA, Agresta S, Yen K, MacBeth K, Stein E, Vassiliou GS, Levine R, De Botton S, Thakurta A, Penard-Lacronique V, Vyas P.

Nat Med. 2018 Aug;24(8):1167-1177. doi: 10.1038/s41591-018-0115-6. Epub 2018 Jul 16.

PMID:
30013198
7.

Angiotropism and extravascular migratory metastasis in cutaneous and uveal melanoma progression in a zebrafish model.

Fornabaio G, Barnhill RL, Lugassy C, Bentolila LA, Cassoux N, Roman-Roman S, Alsafadi S, Del Bene F.

Sci Rep. 2018 Jul 11;8(1):10448. doi: 10.1038/s41598-018-28515-6.

8.

The Association Between Vitamin D Level and Restless Legs Syndrome: A Population-Based Case-Control Study.

Wali S, Alsafadi S, Abaalkhail B, Ramadan I, Abulhamail B, Kousa M, Alshamrani R, Faruqui H, Faruqui A, Alama M, Hamed M.

J Clin Sleep Med. 2018 Apr 15;14(4):557-564. doi: 10.5664/jcsm.7044.

9.

[Uveal melanoma, a model disease for splicing alterations and oncogenesis].

Alsafadi S, Mobuchon L, Rodrigues M, Stern MH.

Med Sci (Paris). 2018 Feb;34(2):155-160. doi: 10.1051/medsci/20183402013. Epub 2018 Feb 16. Review. French.

10.

Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.

Alsafadi S, Houy A, Battistella A, Popova T, Wassef M, Henry E, Tirode F, Constantinou A, Piperno-Neumann S, Roman-Roman S, Dutertre M, Stern MH.

Nat Commun. 2016 Feb 4;7:10615. doi: 10.1038/ncomms10615.

11.

Nuclear localization of the caspase-3-cleaved form of p73 in anoikis.

Alsafadi S, Tourpin S, Bessoltane N, Salomé-Desnoulez S, Vassal G, André F, Ahomadegbe JC.

Oncotarget. 2016 Mar 15;7(11):12331-43. doi: 10.18632/oncotarget.6329.

12.

Chk1 as a new therapeutic target in triple-negative breast cancer.

Albiges L, Goubar A, Scott V, Vicier C, Lefèbvre C, Alsafadi S, Commo F, Saghatchian M, Lazar V, Dessen P, Delaloge S, André F, Quidville V.

Breast. 2014 Jun;23(3):250-8. doi: 10.1016/j.breast.2014.02.004. Epub 2014 Mar 15.

PMID:
24636978
13.

Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers.

Alsafadi S, Even C, Falet C, Goubar A, Commo F, Scott V, Quidville V, Albiges L, Dieci MV, Guegan J, Lazar V, Ahomadegbe JC, Delaloge S, André F.

Clin Breast Cancer. 2013 Oct;13(5):401-8. doi: 10.1016/j.clbc.2013.02.001. Epub 2013 Jul 3.

PMID:
23830798
14.

Targeting the deregulated spliceosome core machinery in cancer cells triggers mTOR blockade and autophagy.

Quidville V, Alsafadi S, Goubar A, Commo F, Scott V, Pioche-Durieu C, Girault I, Baconnais S, Le Cam E, Lazar V, Delaloge S, Saghatchian M, Pautier P, Morice P, Dessen P, Vagner S, André F.

Cancer Res. 2013 Apr 1;73(7):2247-58. doi: 10.1158/0008-5472.CAN-12-2501. Epub 2013 Jan 28.

15.

P53 family: at the crossroads in cancer therapy.

Alsafadi S, Tourpin S, André F, Vassal G, Ahomadegbe JC.

Curr Med Chem. 2009;16(32):4328-44. Review.

PMID:
19754415
16.

Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.

Faridoni-Laurens L, Tourpin S, Alsafadi S, Barrois M, Temam S, Janot F, Koscielny S, Bosq J, Bénard J, Ahomadegbe JC.

Cell Cycle. 2008 Jun 1;7(11):1587-96. Epub 2008 Mar 2.

PMID:
18469517

Supplemental Content

Loading ...
Support Center